Show pageOld revisionsBacklinksBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== Ocular Complications from Chemotherapeutic Agents ====== ==== MEK inhibitors ==== * Selumetinib, Binimetinib, Trametinib, Cobimetinib * Blurred vision, diplopia, eyelid edema, subconjunctival hemorrhage, increased lacrimation * Retinal pigment epithelial detachment, Central serous-like retinopathy ====References==== * [[https://1drv.ms/b/c/31d83ae8e55e0542/ERC5LNJpRMBEuMqgnPkrivMBz0aY8tspvomR00t6YZzhng?e=BaC6F7|Ocular toxicities of MEK inhibitors and other targeted therapies. Stjepanovic et al. Annals of Oncology.Volume 27, Issue 6, June 2016, Pages 998-1005]] * [[https://1drv.ms/b/c/31d83ae8e55e0542/EYA8uzBJ-_BBiRnZReDu7NUBqsbAxKVJqHK3n-dqPKIwmw?e=DZwwKg |Clinical and Morphological Characteristics of MEK Inhibitor-Associated Retinopathy. Francis, Jasmine H. et al. Ophthalmology. 2017-12, Vol.124 (12), p.1788-1798]]